Wiley.com

User login

Press Releases

  • November 03, 2010
    A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model of inflammatory arthritis that mimics RA, in reducing disease severity and inflammation, and promoting bone healing. Full findings of this study are published in the November issue of Arthritis...
  • November 03, 2010
    Researchers from the Cincinnati Children’s Hospital Medical Center observed a statistically significant increase in mean height, weight, and body mass index (BMI) percentiles in patients with juvenile idiopathic arthritis (JIA) who were treated with etanercept or etanercept plus methotrexate (MTX). JIA patients treated with MTX alone did not display an increase in growth percentiles. Results of the 3-year study are available online and in the November issue of Arthritis & Rheumatism, a...
  • November 01, 2010
    HOBOKEN, N.J.--(BUSINESS WIRE)--Best-selling author and marketing and public relations expert David Meerman Scott today released an e-book titled Real-Time: How Marketing & PR at Speed Drives Measurable Success, in which he reveals the results of his latest business experiment; a look at the real-time engagement level of the Fortune 100 companies. Portions of this e-book appear in Scott’s most recent book, REAL-TIME MARKETING & PR: How...
  • October 27, 2010
    Duke University and University of North Carolina (UNC) researchers report in the November issue of Arthritis Care & Research that narcotics and diagnostic testing are overused in treating chronic neck pain. Their findings indicate clinicians may overlook more effective treatments for neck pain, such as therapeutic exercise. According to reviews cited in the study, evidence to support the effectiveness of therapeutic exercise in treating chronic neck pain is good, yet only 53% of subjects...
  • October 25, 2010
    Offering colorectal cancer screening to poor minority women during mammography visits can effectively expand screening in this otherwise underserved population, although lack of medical insurance remains a significant barrier. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The results highlight the need to find alternative funding sources for colorectal cancer screening from the government or private institutions....
  • October 21, 2010
    Two new studies have determined that everolimus-eluting stent (EES) implantation reduced the incidence of restenosis and repeat revascularization in patients with calcified culprit lesions, and had fewer clinical events. Results show the rate of major cardiac adverse events in EES-treated patients with calcified lesions were higher than in those for noncalcified lesions, but remained lower than the results of previously reported stent studies. Details of both studies are published in the...
  • October 19, 2010
    A research team from Emory University School of Medicine investigated the role between adiponectin and leptin in obesity-related carcinogenesis. Their findings, published in the November issue of Hepatology, suggest that the protein hormone adiponectin has potential for inhibiting the oncogenic actions of leptin, namely in hepatocellular carcinoma (HCC), and could offer a promising therapy for the disease.Obesity is on the rise and is associated with increased risk and progression of a number...
  • October 19, 2010
    Researchers at the University of Palermo in Italy provide the evidence that a higher visceral adiposity index score—a new index of adipose dysfunction—has a direct correlation with viral load and is independently associated with both steatosis and necroinflammatory activity in patients with genotype 1 chronic hepatitis C (G1 CHC). Details of this study are available in the November issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study...
  • October 14, 2010
    A study of medical records in Hong Kong revealed 66 cases where people were suspected to have been poisoned by a “natural” slimming therapy. In eight cases the people became severely ill, and in one case the person died. The study is published today in the British Journal of Clinical Pharmacology.The desire for a quick-fix for obesity fuels a lucrative market in so-called natural remedies. But a study of medical records in Hong Kong revealed 66 cases where people were suspected to have been...
  • October 12, 2010
    HOBOKEN, N.J.--(BUSINESS WIRE)--Legendary investor Ken Fisher’s latest book DEBUNKERY: Learn It, Do It, and Profit From it—Seeing Through Wall Street’s Money-Killing Myths (Wiley; October 2010; $27.95; hardcover) challenges and refutes common, widely held investing myths and misperceptions; maxims that rob investors and kill profits. “Every investor, me included, makes lots of mistakes—but a huge part of success is avoiding common errors most investors...